vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and Third Coast Bancshares, Inc. (TCBX). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $57.7M, roughly 1.3× Third Coast Bancshares, Inc.). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 17.5%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Third Coast Bancshares, Inc. is a regional financial holding company headquartered in the U.S. Gulf Coast region. It provides a full suite of commercial and retail banking services including deposit products, business and consumer loans, mortgage services, and wealth management solutions, serving local small and medium-sized enterprises, individual consumers, and community clients across Texas and surrounding areas.
PBYI vs TCBX — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $57.7M |
| Net Profit | — | $16.4M |
| Gross Margin | 69.3% | — |
| Operating Margin | 22.7% | — |
| Net Margin | — | 28.4% |
| Revenue YoY | 27.7% | — |
| Net Profit YoY | — | 20.5% |
| EPS (diluted) | $0.26 | $0.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $57.7M | ||
| Q4 25 | $75.5M | $56.5M | ||
| Q3 25 | $54.5M | $54.5M | ||
| Q2 25 | $52.4M | $52.0M | ||
| Q1 25 | $46.0M | $45.9M | ||
| Q4 24 | $59.1M | $46.3M | ||
| Q3 24 | $80.5M | $42.9M | ||
| Q2 24 | $47.1M | $41.7M |
| Q1 26 | — | $16.4M | ||
| Q4 25 | — | $17.9M | ||
| Q3 25 | $8.8M | $18.1M | ||
| Q2 25 | $5.9M | $16.7M | ||
| Q1 25 | $3.0M | $13.6M | ||
| Q4 24 | — | $13.7M | ||
| Q3 24 | $20.3M | $12.8M | ||
| Q2 24 | $-4.5M | $10.8M |
| Q1 26 | — | — | ||
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 22.7% | 38.1% | ||
| Q3 25 | 17.6% | 41.9% | ||
| Q2 25 | 12.7% | 40.5% | ||
| Q1 25 | 8.7% | 37.8% | ||
| Q4 24 | 22.6% | 38.7% | ||
| Q3 24 | 27.4% | 37.9% | ||
| Q2 24 | -4.6% | 34.1% |
| Q1 26 | — | 28.4% | ||
| Q4 25 | — | 31.7% | ||
| Q3 25 | 16.2% | 33.1% | ||
| Q2 25 | 11.2% | 32.2% | ||
| Q1 25 | 6.5% | 29.6% | ||
| Q4 24 | — | 29.7% | ||
| Q3 24 | 25.2% | 29.8% | ||
| Q2 24 | -9.6% | 25.9% |
| Q1 26 | — | $0.88 | ||
| Q4 25 | $0.26 | $1.02 | ||
| Q3 25 | $0.17 | $1.03 | ||
| Q2 25 | $0.12 | $0.96 | ||
| Q1 25 | $0.06 | $0.78 | ||
| Q4 24 | $0.40 | $0.80 | ||
| Q3 24 | $0.41 | $0.74 | ||
| Q2 24 | $-0.09 | $0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | — |
| Total DebtLower is stronger | $22.7M | — |
| Stockholders' EquityBook value | $130.3M | $650.5M |
| Total Assets | $216.3M | $6.6B |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $97.5M | $175.2M | ||
| Q3 25 | $94.4M | $116.4M | ||
| Q2 25 | $96.0M | $113.1M | ||
| Q1 25 | $93.2M | $219.0M | ||
| Q4 24 | $101.0M | $371.2M | ||
| Q3 24 | $96.7M | $258.2M | ||
| Q2 24 | $96.8M | $241.8M |
| Q1 26 | — | — | ||
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — |
| Q1 26 | — | $650.5M | ||
| Q4 25 | $130.3M | $531.0M | ||
| Q3 25 | $115.3M | $513.8M | ||
| Q2 25 | $104.7M | $496.1M | ||
| Q1 25 | $97.1M | $479.8M | ||
| Q4 24 | $92.1M | $460.7M | ||
| Q3 24 | $71.1M | $450.5M | ||
| Q2 24 | $48.5M | $435.0M |
| Q1 26 | — | $6.6B | ||
| Q4 25 | $216.3M | $5.3B | ||
| Q3 25 | $202.9M | $5.1B | ||
| Q2 25 | $194.9M | $4.9B | ||
| Q1 25 | $196.2M | $4.9B | ||
| Q4 24 | $213.3M | $4.9B | ||
| Q3 24 | $220.7M | $4.6B | ||
| Q2 24 | $205.0M | $4.5B |
| Q1 26 | — | — | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | — |
| Free Cash FlowOCF − Capex | $14.4M | — |
| FCF MarginFCF / Revenue | 19.1% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $50.8M | ||
| Q3 25 | $9.7M | $20.7M | ||
| Q2 25 | $14.1M | $13.9M | ||
| Q1 25 | $3.6M | $10.5M | ||
| Q4 24 | $15.6M | $35.1M | ||
| Q3 24 | $11.0M | $22.0M | ||
| Q2 24 | $1.0M | $7.3M |
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | $33.4M | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 26.4% | 72.1% | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | 3.8% | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.84× | ||
| Q3 25 | 1.10× | 1.15× | ||
| Q2 25 | 2.41× | 0.83× | ||
| Q1 25 | 1.21× | 0.77× | ||
| Q4 24 | — | 2.56× | ||
| Q3 24 | 0.54× | 1.72× | ||
| Q2 24 | — | 0.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PBYI
Segment breakdown not available.
TCBX
| Net Interest Income | $53.6M | 93% |
| Noninterest Income | $4.0M | 7% |
